Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe

Giulia Veronesi, David R. Baldwin, Claudia I. Henschke, Simone Ghislandi, Sergio Iavicoli, Matthijs Oudkerk, Harry J. De Koning, Joseph Shemesh, John K. Field, Javier J. Zulueta, Denis Horgan, Lucia Fiestas Navarrete, Maurizio Valentino Infante, Pierluigi Novellis, Rachael L. Murray, Nir Peled, Cristiano Rampinelli, Gaetano Rocco, Rzyman Witold, Giorgio Vittorio ScagliottiMartin C. Tammemagi, Luca Bertolaccini, Natthaya Triphuridet, Rowena Yip, Alexia Rossi, Suresh Senan, Giuseppe Ferrante, Kate Brain, Carlijn van der Aalst, Lorenzo Bonomo, Dario Consonni, Jan P. Van Meerbeeck, Patrick Maisonneuve, Silvia Novello, Anand Devaraj, Zaigham Saghir, Giuseppe Pelosi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the disease. European mortality data has recently become available from the Nelson randomised controlled trial, which confirmed lung cancer mortality reductions by 26% in men and 39–61% in women. Recent studies in Europe and the USA also showed positive results in screening workers exposed to asbestos. All European experts attending the “Initiative for European Lung Screening (IELS)”—a large international group of physicians and other experts concerned with lung cancer—agreed that LDCT-LCS should be implemented in Europe. However, the economic impact of LDCT-LCS and guidelines for its effective and safe implementation still need to be formulated. To this purpose, the IELS was asked to prepare recommendations to implement LCS and examine outstanding issues. A subgroup carried out a comprehensive literature review on LDCT-LCS and presented findings at a meeting held in Milan in November 2018. The present recommendations reflect that consensus was reached.

Original languageEnglish
Article number1672
Pages (from-to)1-24
Number of pages24
JournalCancers
Volume12
Issue number6
DOIs
StatePublished - Jun 2020

Funding

FundersFunder number
Royal Dutch Academy of Sciences
Varian Medical Systems
Horizon 2020 Framework Programme848294
Horizon 2020 Framework Programme
ViewRay
ZonMw
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Associazione Italiana per la Ricerca sul Cancro

    Keywords

    • Computed tomography
    • Consensus
    • Implementation
    • Low dose
    • Lung cancer
    • Mortality
    • Reduction
    • Screening
    • Statement

    Fingerprint

    Dive into the research topics of 'Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe'. Together they form a unique fingerprint.

    Cite this